glp-1 drug delivery devices Navigating use in therapy Improving drug-like properties of insulin
Description
PLoS One 9: e94151, 2014
However, due to its indicated short half-live, GLP-1 peptide is an unattractive therapeutic agent on itself, which stimulated the quest for GLP-1 based compounds with better bioavailability
The 503A pathway for individual patient prescriptions by state-licensed pharmacies remains intact
It would be irresponsible for us to make you think otherwise
These surgeries were lengthy, required large incisions and often caused complications
Accessed August 21, 2012
